IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S: Financial statements 2016
CVR: 16584037
Source: annual report 2016, Danish Business Authority
01/04/2015 – 31/03/2016
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S (CVR 16584037) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 8,485,852 and a net result of DKK 6,107,917 compared with DKK 5,980,943 the year before. That is a decrease of 5.2% compared with the year before. Equity in the 2016 report amounted to DKK 90,811,240. The solvency ratio was 99.3%.
- Gross Profit
- DKK 8,485,852
- Profit/Loss
- DKK 6,107,917
- Equity
- DKK 90,811,240
- Total Assets
- DKK 91,473,169
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 8.5M | 6.1M | 90.8M | - |
| 2015 | - | 9M | 6M | 84.7M | - |
| 2014 | - | 13.4M | 9.2M | 78.7M | - |
| 2013 | - | 11.7M | 7.1M | 69.5M | - |
Official annual report
Find more companies like IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S was a Danish company of the type Aktieselskab based in København S, founded in 1992. The company has been dissolved on 11 October 2019. The company was registered under the industry Engroshandel med kemiske produkter. The company was previously named NORDIC BIOSCIENCE DIAGNOSTICS A/S and OSTEOMETER BIOTECH A/S. The company has 1 employee (2018). In 2019, the company reported a gross profit of DKK 877,018 and a net result of DKK 1,209,814 compared with DKK 5,073,540 the year before. Equity in the 2019 report amounted to DKK 102,384,800.